Sharper MRI Zoom Technique Reveals Tumor Edges but Shifts Key Cancer Numbers

Gastric cancer remains one of the world’s most lethal malignancies, and magnetic resonance imaging has become an increasingly important tool for mapping tumors before surgery or treatment. Now a team of radiologists in China has put two competing MRI diffusion techniques head to head in patients with stomach cancer, and the results offer a nuanced verdict: a newer, sharper imaging method genuinely improves how clearly doctors can see the edges of a tumor, but it quietly distorts one of the most important numbers radiologists rely on to characterize disease. The study, published in BMC Medical Imaging, suggests the new technique should be treated as a complement to conventional imaging rather than a replacement, a conclusion with immediate practical consequences for imaging departments around the world.

The two techniques in question are both built on diffusion-weighted imaging, or DWI, a cornerstone of modern oncological MRI. DWI works by sensitizing the MRI signal to the random Brownian motion of water molecules. In dense, cellular tumors, water molecules bump into cell membranes and extracellular matrix far more often than they do in loose, healthy tissue, so water diffusion is restricted and the tumor lights up brightly on DWI images. From these images radiologists calculate a quantity called the apparent diffusion coefficient, or ADC, which quantifies diffusion numerically. Lower ADC values generally correspond to more cellular, more aggressive tissue, and ADC thresholds are widely used to help distinguish malignant from benign lesions, to assess treatment response, and to characterize tumors across the body.

Conventional DWI, which the researchers call General-DWI, uses a well-established acquisition method known as single-shot echo-planar imaging combined with parallel imaging. It covers the entire field of view in one rapid sweep, which makes it fast and robust, but it comes with an inherent trade-off: the large field of view and the physics of echo-planar readouts introduce geometric distortion, blurring, and image noise, particularly in the abdomen, where breathing motion and nearby air-filled organs degrade image quality. For gastric cancer specifically, where lesions can be small and sit amid a tangle of motion-prone anatomy, those artifacts can blur the very margins clinicians most need to see.

Enter Zoom-DWI, short for zonally oblique multi-slice diffusion-weighted imaging. Instead of exciting the whole imaging volume and then reconstructing the slice of interest, Zoom-DWI uses a targeted, two-dimensional radiofrequency excitation scheme that excites only a thin, obliquely oriented slab containing the anatomy of interest. By never exciting tissue outside that zone in the first place, the technique avoids the aliasing and fold-over artifacts that conventional acquisitions must otherwise suppress with parallel imaging acceleration. The theoretical payoff is a smaller effective field of view, reduced distortion, and crisper anatomical detail, all without requiring the patient to hold their breath, since the sequence is acquired during free breathing. The technique has shown promise in other organs, including prostate and breast imaging, but its behavior in gastric cancer had not been systematically benchmarked against conventional DWI until now.

The research team, led by radiologists at Daping Hospital of Army Medical University in Chongqing, conducted a single-center retrospective study of 70 patients with histopathologically confirmed gastric cancer who underwent abdominal MRI between March 2023 and October 2024. Each patient received both sequences: the conventional free-breathing, fat-suppressed General-DWI and the targeted Zoom-DWI. The investigators then evaluated the two techniques on three fronts. First, they scored image quality qualitatively on a five-point scale, with two independent readers assessing features such as tumor boundary delineation and image noise. Second, they measured mean ADC values within carefully drawn tumor regions of interest. Third, they computed entropy metrics, a texture-analysis measure that captures the heterogeneity, or spatial irregularity, of the signal within the tumor, which some researchers hope can serve as an imaging proxy for tumor aggressiveness.

The headline finding on image quality was a genuine split decision. Zoom-DWI scored significantly higher for tumor boundary delineation, with a mean score of 3.78 compared with lower scores for the conventional technique, a difference that was highly statistically significant. In plain terms, radiologists could see where the tumor ended and healthy tissue began more clearly with the zoomed approach, which matters enormously for staging, treatment planning, and targeting biopsies. But the sharper view came at a cost: Zoom-DWI performed significantly worse on image noise, scoring 3.76 on the noise assessment, indicating that the targeted excitation approach produces grainier, less clean images than the conventional method. This trade-off between spatial clarity and noise is a familiar refrain in MRI physics, but quantifying it in gastric cancer provides practical guidance for radiologists deciding which sequence to deploy.

The quantitative results revealed something more consequential. General-DWI produced significantly higher ADC values than Zoom-DWI: 1.43 versus 1.33 in the standard units of ten-thousandths of a square millimeter per second, a difference that was highly significant. To dig deeper, the team applied linear mixed-effects modeling, a statistical framework that can separate true sequence effects from patient-to-patient variability. The modeling revealed a systematic ADC underestimation bias of 0.096 associated with Zoom-DWI, meaning the zoomed technique consistently reads diffusion as slightly more restricted than the conventional method does in the same tumor. This is not random scatter; it is a predictable, directional shift baked into the physics of the acquisition.

Why does this matter so much? Because ADC values are not just descriptive numbers, they are diagnostic instruments. Radiologists and researchers have accumulated years of threshold-based criteria, for example cutoffs used to separate malignant from benign tissue or to grade treatment response, all calibrated against conventional DWI acquisitions. If a department switches to Zoom-DWI and plugs its measurements into those established thresholds, the systematic bias could push borderline lesions across diagnostic cutoffs and change clinical decisions. The correlation between the two techniques was extremely strong for ADC, with a Pearson correlation coefficient of 0.906, and strong for entropy at 0.776, meaning the two methods track each other well in relative terms. But correlation is not agreement. Bland-Altman analysis, the standard statistical tool for assessing whether two measurement methods can be used interchangeably, revealed consistent systematic ADC deviation between the sequences and wide variation in entropy measurements. The authors’ conclusion is unambiguous: the two sequences cannot share unified quantitative diagnostic cutoffs.

Entropy, interestingly, emerged as the more forgiving metric. Mean entropy values were statistically indistinguishable between the two sequences, at 4.70 for Zoom-DWI and 4.72 for General-DWI, a difference with no statistical significance. This suggests that texture heterogeneity measurements may be more robust to the choice of acquisition technique than ADC values are, an encouraging sign for researchers pursuing radiomics approaches to gastric cancer characterization. However, the wide limits of agreement observed for entropy in the Bland-Altman analysis caution against assuming that individual patient measurements can be swapped freely between sequences, even if group-level means agree.

The study’s practical message for clinics is measured and clear. Zoom-DWI delivers superior visualization of tumor margins, which could improve staging accuracy and help clinicians delineate disease, but it carries higher image noise and produces systematically lower ADC values that are incompatible with existing diagnostic thresholds. The authors therefore recommend that Zoom-DWI serve only as a complementary sequence in gastric cancer MRI, deployed when crisp anatomical delineation is the priority, while conventional DWI remains the backbone for quantitative ADC-based assessments. For patients, the takeaway is that the sharper picture on the radiologist’s screen is real and valuable, but the numbers behind it must be interpreted in the context of the technique that produced them. As targeted diffusion imaging spreads through clinical practice, this study offers a timely reminder that in medical imaging, seeing better and measuring the same are two very different achievements, and that the transition between techniques demands recalibration, not just enthusiasm.

Subject of Research: Comparison of Zoom-DWI and conventional diffusion-weighted MRI for image quality, ADC values, and entropy in gastric cancer imaging

Article Title: Zoom-DWI versus general-DWI in gastric cancer: a comparative evaluation of image quality, apparent diffusion coefficient, and entropy

Article References: Xie, H., Wang, H., Cao, Z., Zhao, M., Chen, D., Guo, Y., Liu, J., Zhang, L., Wang, X., Ran, Q., & Wang, S. (2026). Zoom-DWI versus general-DWI in gastric cancer: a comparative evaluation of image quality, apparent diffusion coefficient, and entropy. BMC Medical Imaging. https://doi.org/10.1186/s12880-026-02766-6

Image Credits: AI Generated

DOI: 10.1186/s12880-026-02766-6

Keywords: gastric cancer, diffusion-weighted imaging, Zoom-DWI, apparent diffusion coefficient, MRI, image quality, entropy, echo-planar imaging, radiology, tumor delineation, Bland-Altman analysis, cancer imaging